Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the potential effect of administration of tradipitant on
CYP3A4 using midazolam pharmacokinetics as markers.
The study will also further characterize the pharmacokinetics of tradipitant.